Back
Theravance Biopharma Quote, Financials, Valuation and Earnings
Sponsored
TBPH
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
42
TBPH
Theravance Biopharma
Last Price:
9.46
Seasonality Move:
-14.12%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right hereTheravance Biopharma Price Quote
$9.46
Theravance Biopharma Key Stats
Sell
42
Theravance Biopharma (TBPH)
is a Sell
Day range:
$9.29 - $9.63
52-week range:
$8.21 - $11.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.12
P/B ratio:
2.14%
Volume:
330.8K
Avg. volume:
450.7K
1-year change:
-15.84%
Market cap:
$455.6M
Revenue:
$57.4M
EPS:
$-0.97
How Much Does Theravance Biopharma Make?
-
How Much Are Theravance Biopharma's Sales Annually?
TBPH Revenues are $57.4M -
How Much Profit Does Theravance Biopharma's Make A Year?
TBPH net income is -$55.2M
Is Theravance Biopharma Growing As A Company?
-
What Is Theravance Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.2% -
What Is Theravance Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Theravance Biopharma Stock Price Performance
-
Did Theravance Biopharma Stock Go Up Last Month?
Theravance Biopharma share price went up by 1.83% last month -
Did TBPH's Share Price Rise Over The Last Year?
TBPH share price fell by -15.84% over the past 1 year
What Is Theravance Biopharma 52-Week High & Low?
-
What Is Theravance Biopharma’s 52-Week High Share Price?
Theravance Biopharma has traded as high as $11.98 over the past 52 weeks -
What Is Theravance Biopharma’s 52-Week Low Share Price?
Theravance Biopharma has traded as low as $8.21 over the past 52 weeks
Theravance Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Theravance Biopharma?
-
How Much Debt Does Theravance Biopharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Theravance Biopharma Have?
Cash and short term investments quarterly total is $102.4M -
What Is Theravance Biopharma’s Book Value Per Share?
Book value per share is 4.43
Is Theravance Biopharma Cash Flow Positive?
-
What Is TBPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$27M -
What Is Theravance Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$198.9M -
What Is Theravance Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$32.7M
Theravance Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
TBPH return on invested capital is -17.79% -
What Is Theravance Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -11.56% -
What Is TBPH Return On Equity?
ROE is a measure of profitability and is -17.79%
Theravance Biopharma Earnings Date & Stock Price
-
What Is Theravance Biopharma's Stock Price Today?
A single share of TBPH can be purchased today for 9.46 -
What Is Theravance Biopharma’s Stock Symbol?
Theravance Biopharma trades on the nasdaq under the ticker symbol: TBPH -
When Is Theravance Biopharma’s Next Earnings Date?
The next quarterly earnings date for Theravance Biopharma is scheduled on May 13, 2024 -
When Is TBPH's next ex-dividend date?
Theravance Biopharma's next ex-dividend date is May 4, 2024 -
How To Buy Theravance Biopharma Stock?
You can buy Theravance Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Theravance Biopharma Competitors
-
Who Are Theravance Biopharma's Competitors?
Below is a list of companies who compete with Theravance Biopharma or are related in some way:
Theravance Biopharma Dividend Yield
Data Unavailable
Theravance Biopharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 970.87% |
Revenue: | 19.91% | -0.06% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 15.40 |
Upside from Last Price: | 62.79% |